On Invalid Date, ABBVIE (NYSE: ABBV) reported Q1 2022 earnings per share (EPS) of $2.52, up 26% year over year. Total ABBVIE earnings for the quarter were $4.49 billion. In the same quarter last year, ABBVIE's earnings per share (EPS) was $2.00.
What was ABBV's earnings growth in the past year?
As of Q2 2022, ABBVIE's earnings has grown 150.54% year over year. This is 53.25 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 97.28%. ABBVIE's earnings in the past year totalled $12.48 billion.
What was ABBV's revenue last quarter?
On Invalid Date, ABBVIE (NYSE: ABBV) reported Q1 2022 revenue of $13.54 billion up 4.06% year over year. In the same quarter last year, ABBVIE's revenue was $13.01 billion.
What was ABBV's revenue growth in the past year?
As of Q2 2022, ABBVIE's revenue has grown 13.01% year over year. This is 11.9 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 24.91%. ABBVIE's revenue in the past year totalled $56.73 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.